Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis (2022)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1093/rheumatology/keab597
- Subjects: MIOSITE; REUMATOLOGIA; IMUNIDADE; MORTALIDADE; ADULTOS; SOBREVIDA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Rheumatology
- ISSN: 1462-0324
- Volume/Número/Paginação/Ano: v. 61, n. 4, p. 1579-1588, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HOFF, Leonardo S. et al. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis. Rheumatology, v. 61, n. 4, p. 1579-1588, 2022Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab597. Acesso em: 24 fev. 2026. -
APA
Hoff, L. S., Souza, F. H. C. de, Miossi, R., & Shinjo, S. K. (2022). Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis. Rheumatology, 61( 4), 1579-1588. doi:10.1093/rheumatology/keab597 -
NLM
Hoff LS, Souza FHC de, Miossi R, Shinjo SK. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis [Internet]. Rheumatology. 2022 ; 61( 4): 1579-1588.[citado 2026 fev. 24 ] Available from: https://doi.org/10.1093/rheumatology/keab597 -
Vancouver
Hoff LS, Souza FHC de, Miossi R, Shinjo SK. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis [Internet]. Rheumatology. 2022 ; 61( 4): 1579-1588.[citado 2026 fev. 24 ] Available from: https://doi.org/10.1093/rheumatology/keab597 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Informações sobre o DOI: 10.1093/rheumatology/keab597 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
